Anagenics Ltd has released a press release.
Appendix 4C Cash Flow & Activities Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Anagenics
- Midkine Antibody Licensing Deal
- Quarterly Activities/Appendix 4C Cash Flow Report
- Organisational Changes
- H1 FY24 Results and Corporate Update
- Appendix 4D and Half Year Report
Later from Anagenics
- Company Update License Partnership Announcement
- Appendix 4E and Preliminary Final Report
- FY24 4E Presentation
- Pause in Trading
- Suspension from Official Quotation
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics